drugset / Trial / NCT02417896

Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery

NCT02417896

Non-randomizedParallel-groupOpen-labelPrevention

Summary

Our aim is to test whether short term perioperative administration of oral spironolactone could reduce incidence of postoperative acute kidney injury (AKI) in cardiac surgical patients.

Timeline

Start
2013-04
Primary completion
2015-07
Completion
2015-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Spironolactone Small molecule 25 mg Oral

Indications